secwatch.observer — SEC 8-K summary
======================================

Issuer:     MANNKIND CORP (MNKD)
CIK:        0000899460
Form:       8-K
Filed at:   2022-09-26T23:59:59+00:00
Accession:  0001564590-22-032286
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

EVP Endocrine Business Unit Alejandro Galindo resigns effective Oct 21, 2022
----------------------------------------------------------------------------

- Alejandro Galindo, Executive Vice President – Endocrine Business Unit, resigns to pursue other opportunity.
- Resignation effective at close of business on October 21, 2022.
- No replacement named or additional details provided in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/899460/000156459022032286/0001564590-22-032286-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/899460/000156459022032286/mnkd-8k_20220923.htm
  HTML page:      https://secwatch.observer/filing/0001564590-22-032286

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer